Viewing Study NCT06942234


Ignite Creation Date: 2025-12-25 @ 2:18 AM
Ignite Modification Date: 2025-12-27 @ 11:31 PM
Study NCT ID: NCT06942234
Status: RECRUITING
Last Update Posted: 2025-09-17
First Post: 2025-04-10
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Study of JSKN016 Combination Therapy in Inoperable Locally Advanced or Metastatic HER2-Negative Breast Cancer
Sponsor: Jiangsu Alphamab Biopharmaceuticals Co., Ltd
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module